Pharma & Bioanalytical

Every calibration curve, verified before it reaches a study report.

Built for bioanalytical CROs and pharma QC laboratories. WLTR shows every candidate model side by side, objectively identifies the best fit, and gives your team documented evidence that the regression and weighting you report are the right fit for your data.

Request a demoJoin the pilot program

1Unified calculation for every calibration
100%Of calibration levels scored
100%Of exclusions logged with a reason
SHA-256Fingerprint on every source file

Why labs switch to WLTR

Review every curve in a run at once, not one analyte at a time.

Chromatography data systems were built to acquire and process data, not to judge a calibration. WLTR does that job objectively, for every analyte, in one view.

How calibrations are reviewed today

  • Your CDS shows one analyte at a time, on one small screen.
  • Curves are checked by hand, analyte by analyte, often in a spreadsheet.
  • The model is chosen by whoever processed the batch, often a junior analyst.
  • QA directors sign off without an objective basis for the curve that was chosen.
With WLTR

  • Every analyte and every candidate model on one screen, in the Calibration Intelligence dashboard, with multi-analyte visibility.
  • Every curve is checked automatically, including back-calculated accuracy at the LLOQ.
  • The best fit is determined objectively: same data, same answer, every time.
  • QA directors review exceptions only, with one unified calculation behind every calibration.
Time back

Hours back every batch

Review by exception instead of one analyte at a time.

Confidence

Peace of mind for QA

An objective, documented basis for every curve that is signed off.

Data quality

Accurate data for sponsors

Results built on the best-fit calibration, not on habit.

Growth

More capacity, more revenue

Faster review frees analysts and QA to take on more work.

What is at stake

When bioanalytical data cannot be trusted, the studies are thrown out.

Since 2016, FDA has notified sponsors that certain studies conducted at five contract research organizations are unacceptable because of data integrity concerns. Sponsors were asked to repeat the affected studies at another site, and affected approved generics were rated BX, no longer recommended as automatically substitutable.

  1. 2016Semler ResearchStudies unacceptable
  2. 2021Synchron Research and Panexcell Clinical LabStudies unacceptable
  3. 2024Synapse LabsStudies unacceptable
  4. 2025Raptim ResearchIn vitro studies unacceptable

Source: FDA, Notifications on Data Integrity. Analysis: FDA data integrity actions against bioanalytical CROs.

The real problems

Six data integrity failures auditors find in bioanalytical labs.

None of them require bad intent. They happen when calibration decisions are made by hand, one analyte at a time, under deadline. Select a problem to see how WLTR closes it.

What goes wrong

Processing until it passes

A failing curve is reprocessed, reintegrated or refit until it meets acceptance, and only the passing version is kept. Auditors call it testing into compliance.

How WLTR closes it

Every candidate model, scored in one pass

WLTR evaluates every candidate model against the same acceptance criteria at once and keeps the full evaluation. There is no curve to shop for and no failed attempt to hide.

What WLTR adds to your data

Your CDS calculates a curve. WLTR shows whether it is the right one.

A passing r² does not prove a model is correct across a wide dynamic range. WLTR independently evaluates your calibration standards, ranks how well each established model describes the concentration response, and documents the result for every run and analyte.

01 · Model selection

Regression and weighting, justified with evidence

ICH M10 expects the regression model, weighting scheme, and transformation to be determined during validation and governed by written procedures. WLTR evaluates the candidate calibration models side by side, so your choice is supported by data rather than habit.

02 · Accuracy at the LLOQ

See the bias a strong r² can hide

WLTR checks every calibration level, including back-calculated accuracy at every level. Bias at the LLOQ and ULOQ surfaces before it reaches a concentration-time profile or a study report.

03 · Multi-analyte oversight

Consistency across runs, instruments, and analytes

Trend calibration performance across batches, instruments, and sites. Spot drift and recurring failures early, before they turn into rejected runs, reassays, or ISR investigations. Multi-analyte oversight

04 · Audit defensibility

A record built for sponsors and auditors

Every evaluation is documented and reproducible, giving QA, study directors, and sponsors a clear answer when they ask why a model and weighting were used. Audit defensibility

See it for yourself

Same eight standards. Three models. Three different answers.

Switch the regression model and watch what happens to back-calculated accuracy. The unweighted linear fit posts an r² above 0.998 and still fails at the low end. This is the gap WLTR is built to close.

Inside WLTR

From raw export to a defensible record.

Step 01

Export from your CDS, upload the run.

Drop in the calibration export from your chromatography data system. WLTR parses the run, maps analytes, and confirms the instrument and method context. Nothing in your validated acquisition or processing changes.

WLTR Upload Run screen with parsed calibration levels and file preview

WLTR complements your validated workflow. It does not replace your CDS, your LIMS, or your method validation. The WLTR methodology is patented (US 12,038,448 B2).

Where calibration risk hides

The calibration problems bioanalytical labs live with.

01

Weighting set once, never revisited

A 1/x² weighting chosen at validation may not suit a new matrix, a new instrument, or a method transferred from another site.

02

Wide dynamic ranges

Over three or four orders of magnitude, the correlation coefficient is dominated by the high standards while accuracy at the low end erodes.

03

Calibrators excluded to pass

Dropping standards within the 75% rule can keep a run acceptable, but a recurring pattern of exclusions usually points to a model problem.

04

Response nonlinearity

Ion suppression, matrix effects, and detector saturation bend LC-MS/MS response curves in ways a linear fit does not capture.

05

ISR and reassay investigations

When incurred sample reanalysis fails or reassays pile up, calibration fit is one of the first places investigators look.

06

Method transfer between sites

The same validated method can behave differently in a receiving laboratory. Comparable calibration evidence makes transfer defensible.

How it works

Three steps. No change to your validated method.

  1. Export

    Export calibration data from your chromatography data system for the runs you want verified.

  2. Evaluate

    WLTR fits your standards against the candidate calibration models, scores each one, and ranks model performance.

  3. Review and document

    Analysts, data reviewers, and QA receive a clear verification result per run and analyte, ready for data review, study files, and audits.

Regulatory alignment

Built around the expectations you already work to.

Calibration expectations and how WLTR supports them
Framework What it expects How WLTR supports it
ICH M10, Bioanalytical Method Validation and Study Sample Analysis (FDA guidance, November 2022) At least six calibration levels including the LLOQ and ULOQ. Back-calculated concentrations within ±15% of nominal, ±20% at the LLOQ, for at least 75% of standards. Regression model and weighting determined during validation under written procedures. Side-by-side model comparison and back-calculated accuracy review that support your model and weighting justification.
21 CFR Part 58, Good Laboratory Practice Nonclinical study data that is complete, accurate, and reconstructable. A reproducible calibration evaluation that can be filed with the run and the study record.
21 CFR 211.160 and 211.194, GMP laboratory controls and records Scientifically sound standards and test procedures, with complete records of calculations and test data. Independent verification evidence for second-person data review and batch record review.
21 CFR Part 11 and ALCOA+ data integrity principles Electronic records that are attributable, accurate, complete, and consistent. An independent check of results produced by your CDS, without altering source data.

Who it is for

Built for the people who sign off on the data.

  • Bioanalytical laboratory directors
  • Study directors and principal investigators
  • QA managers and QAU auditors
  • Method development and validation scientists
  • LC-MS/MS analysts
  • Data reviewers
  • Sponsor quality oversight

Founding pilot · Standard operating procedure

How a founding pilot runs in a bioanalytical lab.

Written the way your own SOPs are: who owns each step, when it happens and how you know it is done. It is the same procedure we follow with every founding lab.

WhoYour QA lead, an analyst lead and your sponsor, with a named WLTR implementation teamWhenFrom acceptance to the outcome studyTimeOne 60-minute scoping session, then thirty minutes every two weeks

When you finish, you will haveEvery calibration in scope verified beside your current review and approved in WLTR by your QA lead, a look back at what a second check would have flagged in your recent runs, and a co-authored outcome study built from your own numbers.

  1. 01

    Apply and confirm fit.

    Your labAbout five minutes

    Tell us your LC-MS/MS instruments, data system, calibration workload, the programs you work to, such as GLP and ICH M10, and who signs off. We accept or decline in writing.

    Done whenYou have a written decision and, if accepted, a kickoff date within fourteen days.

  2. 02

    Scope the pilot together.

    WLTRYour labWithin five business days of acceptance · 60 minutes

    A working session with your QA lead and an analyst lead. We run a representative export from your data system through WLTR together, agree the methods in scope and write down what the pilot must show, measured from your own figures.

    Done whenThe success criteria are written and agreed by your QA lead.

  3. 03

    Share data under NDA.

    Your labBefore kickoff

    Raw calibration exports go to one NDA data location that WLTR names. Nothing by email or chat, and nothing retyped, so the record starts clean.

    Done whenThe first data set is in the NDA location.

  4. 04

    Configure to your validated method.

    WLTRKickoff to go-live

    We set up your instruments, methods, acceptance criteria and roles with you, to your validated method and SOPs, including ICH M10 limits where they apply. Each gate, from method inventory through validation, acceptance and training, is a record your QA lead signs before the next one starts.

    Done whenEvery gate record is signed and your first real run has been processed in WLTR.

  5. 05

    Look back at recent runs.

    WLTRYour labRight after go-live

    Where your data system can export them, the last six to twelve months of calibrations for the methods in scope run through WLTR. You see what a second check would have flagged and the review time it represents. It stays under NDA, is never framed as a finding against your lab, and your QA lead decides what to do with it.

    Done whenYour QA lead has reviewed the first evidence pack.

  6. 06

    Run beside your current review.

    Your labGo-live to the outcome study · thirty minutes with us every two weeks

    Your analysts keep reviewing as they do today, and every calibration in scope also runs through WLTR. Your QA lead approves in WLTR with a named signature, and your current process stays the official record until you decide otherwise. A midpoint review decides whether to keep, fix or expand the scope.

    Done whenEvery calibration in scope has a WLTR record and a QA approval.

  7. 07

    Write the outcome study and decide.

    WLTRYour labEnd of the run

    We draft the outcome study from your pilot’s own numbers and review it with your team. The decision is yours, with no obligation to convert, and founding pricing is locked if you do. Nothing is published without your permission, anonymized if you prefer.

    Done whenThe co-authored study is complete and your decision is recorded.

Never

  • Ask you to change your validated method, your data system or a reported result.
  • Take data by email or chat, or retype a value.
  • Call a result compliant or guaranteed. We state what WLTR checked and what your QA lead approved.
  • Publish anything without your written permission.

Done when

  • Every calibration in scope has a WLTR record and a QA approval.
  • Your QA lead has reviewed the look-back and the outcome study.
  • Your decision is recorded, with founding pricing locked if you convert.

Read the founding pilot program →Limited to five laboratories · No obligation to convert

Questions

Frequently asked questions

Does WLTR replace our CDS or LIMS?

No. Your chromatography data system keeps running as it does today, and your LIMS continues to manage samples and reporting. WLTR is a verification layer that evaluates the calibration data your CDS already produces.

Do we need to change or revalidate our bioanalytical methods to use WLTR?

WLTR works from calibration data you export after a run. It does not change acquisition, integration, or processing in your validated method. How WLTR results are referenced in your SOPs is decided by your quality system.

Which techniques does WLTR support?

WLTR is built for quantitative methods that report against a calibration curve, including LC-MS/MS, HPLC, and UPLC assays used in bioanalysis, pharmacokinetic and toxicokinetic studies, and QC release testing.

How does WLTR help a CRO during sponsor audits and regulatory inspections?

WLTR gives your team a documented, reproducible evaluation of each calibration curve, including how the reported model compares with alternatives and how accurately each standard back-calculates. That record supports the questions sponsors and auditors ask about model selection and weighting.

How do we get started?

Apply to the WLTR Pilot Program or request a demo. We will walk through your workflow and show how WLTR evaluates calibration data from your own runs.

Pilot program

See what WLTR finds in your calibration data.

Bring a recent run. We will show you how your reported curve compares with the best-fit model, analyte by analyte.

Apply to the pilot programRequest a demo

References: ICH M10 Bioanalytical Method Validation and Study Sample Analysis (FDA) · 21 CFR Part 58 · 21 CFR Part 211